Compare Tata India Pharma & Healthcare Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.13
2.27
NAV
₹29.59
₹281.99
Fund Started
04 Dec 2015
01 Aug 2005
Fund Size
₹1300.81 Cr
₹1106.71 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 30 days.
1 Year
7.72%
10.11%
3 Year
23.71%
25.64%
5 Year
15.18%
15.33%
Equity
97.56%
98.21%
Cash
2.44%
1.79%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.66% |
Max Healthcare Institute Ltd. | 6.78% |
Divi's Laboratories Ltd. | 5.94% |
Abbott India Ltd. | 5.60% |
Healthcare Global Enterprises Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 5.00% |
Cipla Ltd. | 4.55% |
Rainbow Children's Medicare Ltd. | 3.83% |
Mankind Pharma Ltd. | 3.40% |
Bayer CropScience Ltd. | 3.33% |
Sun Pharmaceutical Industries Ltd. | 9.42% |
Ajanta Pharma Ltd. | 7.04% |
Lupin Ltd. | 5.79% |
Glenmark Pharmaceuticals Ltd. | 4.25% |
Apollo Hospitals Enterprise Ltd. | 3.75% |
Gland Pharma Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.52% |
Dr. Reddy's Laboratories Ltd. | 3.48% |
Alkem Laboratories Ltd. | 3.47% |
Fortis Healthcare Ltd. | 2.98% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
04 Dec 2015
01 Aug 2005
